Literature DB >> 21185816

Lipid bilayer molecular dynamics study of lipid-derived agonists of the putative cannabinoid receptor, GPR55.

Evangelia Kotsikorou1, Diane L Lynch, Mary E Abood, Patricia H Reggio.   

Abstract

Both L-α-lysophosphatidylinositol (LPI) and 2-arachidonoyl-sn-glycero-3-phosphoinositol (2-AGPI) have been reported to activate the putative cannabinoid receptor, GPR55. Recent microsecond time-scale molecular dynamics (MD) simulations and isothiocyanate covalent labeling studies have suggested that a transmembrane helix 6/7 (TMH6/7) lipid pathway for ligand entry may be necessary for interaction with cannabinoid receptors. Because LPI and 2-AGPI are lipid-derived ligands, conformations that each assumes in the lipid bilayer are therefore likely important for their interaction with GPR55. We report here the results of 70 ns NAMD molecular dynamics (MD) simulations of LPI and of 2-AGPI in a fully hydrated bilayer of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC). These simulations are compared with a 70 ns simulation of the cannabinoid CB1 receptor endogenous ligand, N-arachidonoylethanolamine (anandamide, AEA) in a POPC bilayer. These simulations revealed that (1) LPI and 2-AGPI sit much higher in the bilayer than AEA, with inositol headgroups that can at times be solvated completely by water; (2) the behavior of the acyl chains of AEA and 2-AGPI are similar in their flexibilities in the bilayer, while the acyl chain of LPI has reduced flexibility; and (3) both 2-AGPI and LPI can adopt a tilted headgroup orientation by hydrogen bonding to the phospholipid phosphate/glycerol groups or via intramolecular hydrogen bonding. This tilted head group conformation (which represents over 40% of the conformer population of LPI (42.2 ± 3.3%) and 2-AGPI (43.7 ± 1.4%)) may provide a low enough profile in the lipid bilayer for LPI and 2-AGPI to enter GPR55 via the putative TMH6/7 entry port.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21185816      PMCID: PMC3086297          DOI: 10.1016/j.chemphyslip.2010.12.003

Source DB:  PubMed          Journal:  Chem Phys Lipids        ISSN: 0009-3084            Impact factor:   3.329


  34 in total

1.  (-)-7'-Isothiocyanato-11-hydroxy-1',1'-dimethylheptylhexahydrocannabinol (AM841), a high-affinity electrophilic ligand, interacts covalently with a cysteine in helix six and activates the CB1 cannabinoid receptor.

Authors:  Robert P Picone; Atmaram D Khanolkar; Wei Xu; Lionel A Ayotte; Ganesh A Thakur; Dow P Hurst; Mary E Abood; Patricia H Reggio; Donna J Fournier; Alexandros Makriyannis
Journal:  Mol Pharmacol       Date:  2005-09-12       Impact factor: 4.436

2.  Structure of docosahexaenoic acid-containing phospholipid bilayers as studied by (2)H NMR and molecular dynamics simulations.

Authors:  Thomas Huber; Kannan Rajamoorthi; Volker F Kurze; Klaus Beyer; Michael F Brown
Journal:  J Am Chem Soc       Date:  2002-01-16       Impact factor: 15.419

3.  A lipid pathway for ligand binding is necessary for a cannabinoid G protein-coupled receptor.

Authors:  Dow P Hurst; Alan Grossfield; Diane L Lynch; Scott Feller; Tod D Romo; Klaus Gawrisch; Michael C Pitman; Patricia H Reggio
Journal:  J Biol Chem       Date:  2010-03-10       Impact factor: 5.157

4.  Structure of fully hydrated fluid phase lipid bilayers with monounsaturated chains.

Authors:  Norbert Kucerka; Stephanie Tristram-Nagle; John F Nagle
Journal:  J Membr Biol       Date:  2006-04-08       Impact factor: 1.843

5.  Exploration of biologically relevant conformations of anandamide, 2-arachidonylglycerol, and their analogues using conformational memories.

Authors:  J Barnett-Norris; F Guarnieri; D P Hurst; P H Reggio
Journal:  J Med Chem       Date:  1998-11-19       Impact factor: 7.446

6.  Fourier transform infrared spectroscopy of 13C = O-labeled phospholipids hydrogen bonding to carbonyl groups.

Authors:  A Blume; W Hübner; G Messner
Journal:  Biochemistry       Date:  1988-10-18       Impact factor: 3.162

7.  The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects.

Authors:  D G Johns; D J Behm; D J Walker; Z Ao; E M Shapland; D A Daniels; M Riddick; S Dowell; P C Staton; P Green; U Shabon; W Bao; N Aiyar; T-L Yue; A J Brown; A D Morrison; S A Douglas
Journal:  Br J Pharmacol       Date:  2007-08-20       Impact factor: 8.739

8.  The GPR55 ligand L-alpha-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation.

Authors:  Christopher M Henstridge; Nariman A B Balenga; Lesley A Ford; Ruth A Ross; Maria Waldhoer; Andrew J Irving
Journal:  FASEB J       Date:  2008-08-29       Impact factor: 5.191

9.  Phospholipid component volumes: determination and application to bilayer structure calculations.

Authors:  R S Armen; O D Uitto; S E Feller
Journal:  Biophys J       Date:  1998-08       Impact factor: 4.033

10.  Atypical responsiveness of the orphan receptor GPR55 to cannabinoid ligands.

Authors:  Ankur Kapur; Pingwei Zhao; Haleli Sharir; Yushi Bai; Marc G Caron; Larry S Barak; Mary E Abood
Journal:  J Biol Chem       Date:  2009-09-01       Impact factor: 5.157

View more
  7 in total

1.  The Central Role of Glia in Pathological Pain and the Potential of Targeting the Cannabinoid 2 Receptor for Pain Relief.

Authors:  Jenny L Wilkerson; Erin D Milligan
Journal:  ISRN Anesthesiol       Date:  2011

2.  Fingolimod: Lessons Learned and New Opportunities for Treating Multiple Sclerosis and Other Disorders.

Authors:  Jerold Chun; Yasuyuki Kihara; Deepa Jonnalagadda; Victoria A Blaho
Journal:  Annu Rev Pharmacol Toxicol       Date:  2019-01-06       Impact factor: 13.820

3.  Molecular Dynamics Methodologies for Probing Cannabinoid Ligand/Receptor Interaction.

Authors:  Diane L Lynch; Dow P Hurst; Derek M Shore; Mike C Pitman; Patricia H Reggio
Journal:  Methods Enzymol       Date:  2017-07-04       Impact factor: 1.600

Review 4.  Lysophospholipid receptor nomenclature review: IUPHAR Review 8.

Authors:  Yasuyuki Kihara; Michael Maceyka; Sarah Spiegel; Jerold Chun
Journal:  Br J Pharmacol       Date:  2014-07-12       Impact factor: 8.739

5.  Identification of Crucial Amino Acid Residues Involved in Agonist Signaling at the GPR55 Receptor.

Authors:  Mary A Lingerfelt; Pingwei Zhao; Haleli P Sharir; Dow P Hurst; Patricia H Reggio; Mary E Abood
Journal:  Biochemistry       Date:  2017-01-11       Impact factor: 3.162

Review 6.  Minireview: recent developments in the physiology and pathology of the lysophosphatidylinositol-sensitive receptor GPR55.

Authors:  Christopher M Henstridge; Nariman A B Balenga; Julia Kargl; Clara Andradas; Andrew J Brown; Andrew Irving; Cristina Sanchez; Maria Waldhoer
Journal:  Mol Endocrinol       Date:  2011-09-29

7.  The GPR 55 agonist, L-α-lysophosphatidylinositol, mediates ovarian carcinoma cell-induced angiogenesis.

Authors:  Nicole A Hofmann; Jiang Yang; Sunia A Trauger; Hironao Nakayama; Lan Huang; Dirk Strunk; Marsha A Moses; Michael Klagsbrun; Joyce Bischoff; Wolfgang F Graier
Journal:  Br J Pharmacol       Date:  2015-06-26       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.